Juvensis Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$13.8M
- Investors
-
9
Juvensis Therapeutics General Information
Description
Developer of gene therapy drugs designed for the treatment of degenerative diseases. The company's technology leverages proprietary telomere regulation to block mitochondrial dysfunction and drive gene therapy innovation, providing healthcare providers with therapeutic solutions for cardiovascular, neurological, and renal conditions.
Contact Information
Website
www.cn.juvensis.com.cnCorporate Office
- Room 2211, Building R02, Lane 88, Zhangjiang Road
- China (China Pilot Free Trade Zone)
- Shanghai
- China
Corporate Office
- Room 2211, Building R02, Lane 88, Zhangjiang Road
- China (China Pilot Free Trade Zone)
- Shanghai
- China
Juvensis Therapeutics Timeline
Juvensis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 15-Feb-2025 | $13.8M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 20-May-2024 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 07-Mar-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 29-Jul-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 15-Oct-2021 | Completed | Startup |
Juvensis Therapeutics Signals
Juvensis Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jiangbei Investment Group | Growth/Expansion | Minority | ||
| ZhongMei Capital | Venture Capital | Minority | ||
| Hunt Best Capital | Venture Capital | Minority | ||
| Nanjing Jiangbei New Area Innovation Investment Fund Management | PE/Buyout | Minority | ||
| Shanghai Guofang Private Equity Fund Management | Growth/Expansion | Minority |
Juvensis Therapeutics FAQs
-
When was Juvensis Therapeutics founded?
Juvensis Therapeutics was founded in 2021.
-
Where is Juvensis Therapeutics headquartered?
Juvensis Therapeutics is headquartered in Shanghai, China.
-
What is the size of Juvensis Therapeutics?
Juvensis Therapeutics has 4 total employees.
-
What industry is Juvensis Therapeutics in?
Juvensis Therapeutics’s primary industry is Drug Discovery.
-
Is Juvensis Therapeutics a private or public company?
Juvensis Therapeutics is a Private company.
-
What is Juvensis Therapeutics’s current revenue?
The current revenue for Juvensis Therapeutics is .
-
How much funding has Juvensis Therapeutics raised over time?
Juvensis Therapeutics has raised $13.8M.
-
Who are Juvensis Therapeutics’s investors?
Jiangbei Investment Group, ZhongMei Capital, Hunt Best Capital, Nanjing Jiangbei New Area Innovation Investment Fund Management, and Shanghai Guofang Private Equity Fund Management are 5 of 9 investors who have invested in Juvensis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process